Nucleic acid‐mediated inflammatory diseases
暂无分享,去创建一个
[1] Y. Crow,et al. Aicardi‐Goutières syndrome: an important Mendelian mimic of congenital infection , 2008, Developmental medicine and child neurology.
[2] E. Aronica,et al. Astrocytes produce interferon‐alpha and CXCL10, but not IL‐6 or CXCL8, in aicardi‐Goutières syndrome , 2008, Glia.
[3] E. Latz,et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. , 2008, Immunity.
[4] J. Tschopp,et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response , 2008, Nature.
[5] D. Barnes,et al. Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.
[6] M. Lieber,et al. Mechanism of R-Loop Formation at Immunoglobulin Class Switch Sequences , 2007, Molecular and Cellular Biology.
[7] A. Green,et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.
[8] G. Vereb,et al. Ribonucleoprotein-masked nicks at 50-kbp intervals in the eukaryotic genomic DNA , 2007, Proceedings of the National Academy of Sciences.
[9] S. Nelson,et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.
[10] J. Lieberman,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.
[11] K. Honda,et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.
[12] D. Barnes,et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.
[13] G. Gallagher,et al. Interferon lambda-1 (IFN-λ1/IL-29) induces ELR− CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-γ-independent manner , 2007, Genes and Immunity.
[14] J. Derisi,et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors , 2007, Proceedings of the National Academy of Sciences.
[15] Hung Fan,et al. A new human retrovirus associated with prostate cancer , 2007, Proceedings of the National Academy of Sciences.
[16] S. Akira,et al. Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides , 2006, European journal of immunology.
[17] V. Pascual,et al. Systemic lupus erythematosus: all roads lead to type I interferons. , 2006, Current opinion in immunology.
[18] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[19] H. Yoshikawa,et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages , 2006, Nature.
[20] Annalisa Ballarini,et al. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. , 2006, American journal of human genetics.
[21] C. Ponting,et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.
[22] D. Barnes,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.
[23] J. Lieberman,et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. , 2006, Molecular cell.
[24] J. Gómez-Reino,et al. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. , 2006, Rheumatology.
[25] D. J. Driscoll,et al. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. , 2006, Arthritis and rheumatism.
[26] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[27] J. Dalgaard,et al. The wild‐type Schizosaccharomyces pombe mat1 imprint consists of two ribonucleotides , 2006, EMBO reports.
[28] Ram R. Singh. SLE: translating lessons from model systems to human disease. , 2005, Trends in immunology.
[29] S. Akira,et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[30] Miki Ii,et al. Roles of SGS1, MUS81, and RAD51 in the repair of lagging-strand replication defects in Saccharomyces cerevisiae , 2005, Current Genetics.
[31] D. Golenbock,et al. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent , 2005, Cellular microbiology.
[32] L. Lagae,et al. A second locus for Aicardi-Goutières syndrome at chromosome 13q14–21 , 2005, Journal of Medical Genetics.
[33] Y. Crow,et al. Genetic syndromes mimic congenital infections. , 2005, The Journal of pediatrics.
[34] H. Lyall,et al. Clinical presentation of congenital viral infections , 2005 .
[35] S. Miller,et al. Differential activation of astrocytes by innate and adaptive immune stimuli , 2005, Glia.
[36] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[38] H. Shin,et al. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. , 2004, Human molecular genetics.
[39] K. Yasutomo,et al. DNaseI in pathogenesis of systemic lupus erythematosus. , 2004, Clinical immunology.
[40] D. Barnes,et al. Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.
[41] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[42] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[44] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[45] C. Jacobs,et al. Decreased phagocytosis of apoptotic cells in diseased SLE mice. , 2004, Journal of autoimmunity.
[46] P. Heyder,et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. , 2004, Arthritis and rheumatism.
[47] C. J. Evans,et al. DNase II: genes, enzymes and function. , 2003, Gene.
[48] Thierry Heidmann,et al. Survey of Human Genes of Retroviral Origin: Identification and Transcriptome of the Genes with Coding Capacity for Complete Envelope Proteins , 2003, Journal of Virology.
[49] U. Hübscher,et al. DNA polymerase beta can incorporate ribonucleotides during DNA synthesis of undamaged and CPD-damaged DNA. , 2003, Journal of molecular biology.
[50] M. Lieber,et al. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells , 2003, Nature Immunology.
[51] T. Fujikawa,et al. Intracranial Calcification With Congenital Rubella Syndrome in a Mother With Serologic Immunity , 2003, Journal of child neurology.
[52] P. Walsh,et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. , 2003, The Journal of urology.
[53] R. Crouch,et al. Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. , 2003, Molecular cell.
[54] F. Martinon,et al. Overexpression of Helicard, a CARD-Containing Helicase Cleaved during Apoptosis, Accelerates DNA Degradation , 2002, Current Biology.
[55] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[56] K. Klinger,et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.
[57] T. Taniguchi,et al. The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors , 2002 .
[58] Paul B. Fisher,et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[60] T. Horiuchi,et al. Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.
[61] Dan J. Mazur,et al. Structure and Expression of the TREX1 and TREX2 3′→5′ Exonuclease Genes* , 2001, The Journal of Biological Chemistry.
[62] G. Hughes,et al. Systemic lupus erythematosus , 2001, The Lancet.
[63] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[64] M. Itaya,et al. The absence of ribonuclease H1 or H2 alters the sensitivity of Saccharomyces cerevisiae to hydroxyurea, caffeine and ethyl methanesulphonate: implications for roles of RNases H in DNA replication and repair , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[65] D. Isenberg,et al. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.
[66] C. Woods,et al. Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. , 2000, American journal of human genetics.
[67] T. Möröy,et al. Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.
[68] J. Sgouros,et al. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein , 1999, The EMBO journal.
[69] S. Henriksen,et al. Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α 1 Published on the World Wide Web on 17 March 1999. 1 , 1999, Brain Research.
[70] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[71] D. Rebouillat,et al. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[72] M. Itaya,et al. Identification of the genes encoding Mn2+-dependent RNase HII and Mg2+-dependent RNase HIII from Bacillus subtilis: classification of RNases H into three families. , 1999, Biochemistry.
[73] F. Bloom,et al. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. , 1998, Journal of immunology.
[74] P. Frank,et al. Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[75] L. Rönnblom,et al. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. , 1998, Journal of autoimmunity.
[76] R. Voll,et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.
[77] R. Martí,et al. Acrocyanosis Induced by Interferon α2a , 1998, Dermatology.
[78] P. Lachmann,et al. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)‐prone NZB/NZW mice by a new radial enzyme diffusion assay , 1997, Clinical and experimental immunology.
[79] R. Bambara,et al. Enzymes and Reactions at the Eukaryotic DNA Replication Fork* , 1997, The Journal of Biological Chemistry.
[80] D. Farge,et al. Raynaud's phenomenon and digital necrosis induced by interferon‐alpha , 1996, The British journal of dermatology.
[81] A. Raymond,et al. Brain calcification in patients with cerebral lupus , 1996, Lupus.
[82] R. Aguilera,et al. Characterization of an endonuclease activity which preferentially cleaves the G-rich immunoglobulin switch repeat sequences. , 1996, Molecular immunology.
[83] L. Liu,et al. Overexpression of RNase H partially complements the growth defect of an Escherichia coli delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[84] Robert H. Silverman,et al. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.
[85] J. Walder,et al. Ribonuclease H from K562 human erythroleukemia cells. Purification, characterization, and substrate specificity. , 1991, The Journal of biological chemistry.
[86] K. Moelling,et al. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. , 1990, Biochemistry.
[87] J. Farber,et al. Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. , 1990, The Journal of biological chemistry.
[88] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[89] R. Hogrefe,et al. Kinetic analysis of Escherichia coli RNase H using DNA-RNA-DNA/DNA substrates. , 1990, The Journal of biological chemistry.
[90] J. Ravetch,et al. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.
[91] D. Dickson,et al. AIDS: Calcification of the basal ganglia in infants and children , 1986, Neurology.
[92] G. Ponsot,et al. Intrathecal synthesis of different alpha‐interferons in patients with various neurological diseases , 1985, Acta neurologica Scandinavica.
[93] J. Aicardi,et al. A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis , 1984, Annals of neurology.
[94] P. Lebon,et al. Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications. , 1983, British medical journal.
[95] G. Edelman,et al. Properties of Deoxyribonuclease III from Mammalian Tissues , 1969 .
[96] G. Gallagher,et al. Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. , 2007, Genes and immunity.
[97] M. Lieber,et al. Detection and structural analysis of R-loops. , 2006, Methods in enzymology.
[98] L. Pasquier,et al. Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .
[99] P. Backlund,et al. RNase H2 of Saccharomyces cerevisiae is a complex of three proteins. , 2004, Nucleic acids research.
[100] E. Tan,et al. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus , 2004, Rheumatology International.
[101] T. Taniguchi,et al. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. , 2002, Current opinion in immunology.
[102] I. Baumann,et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[103] S. Henriksen,et al. Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. , 1999, Brain research.
[104] R. Martí,et al. Acrocyanosis induced by interferon alpha(2a). , 1998, Dermatology.
[105] J. Bale,et al. Neuroradiographic abnormalities in congenital cytomegalovirus infection. , 1985, Pediatric neurology.
[106] G. Edelman,et al. Properties of deoxyribonuclease 3 from mammalian tissues. , 1969, The Journal of biological chemistry.